ARCHIVES

Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded

This article is from The Cancer Letter archive.

Vol. 24 No. 14 | April 10, 1998

Download PDF Visit The Full Archive

Related Articles

Markison leaving Bristol-Myers, two others promoted in reorganization.

January 30, 2004

DCCR Merit Review Finds some Excellent contract Projects, Some Not So Good; Some Are Terminated

February 25, 1977

Abstract Of Papers From ACTR Meeting

October 22, 1976

Pittsburgh Investigates Use of Resources in Anonymous Mailing To Researchers

April 29, 1994

Anamorelin Increases Body Mass In Two Global Phase III Trials

October 31, 2014

RFA: Native American Women’s Cancer Initiative

July 9, 1993